Article citationsMore>>

Van Dijk, S.M., Hallensleben, N.D.L., van Santvoort, H.C., Fockens, P., van Goor, H., Bruno, M.J. and Besselink, M.G. (2017) Dutch Pancreatitis Study Group. Acute Pancreatitis: Recent Advances through Randomised Trials. Gut, 66, 2024-2032.
https://doi.org/10.1136/gutjnl-2016-313595

has been cited by the following article:

• TITLE: Emodin in Severe Acute Pancreatitis Treatment

  AUTHORS: Weipeng Liu, Qingxia Yuan, Shutong Guo, Zhaoying Fu

  KEYWORDS: Severe Acute Pancreatitis, Multiple Organ Damage, Emodin, Rhubarb

  JOURNAL NAME: Chinese Medicine, Vol.8 No.4, November 27, 2017

  ABSTRACT: Severe acute pancreatitis accounts for 15% - 20% of acute pancreatitis and is a kind of serious systemic disease because it involves multiple organ damage and dysfunction. Emodin is the most important active ingredient of rhubarb and has been used for the treatment of severe acute pancreatitis. This review mainly summarizes the study progress of emodin in severe acute pancreatitis treatment.